Hypoxia regulates human lung fibroblast proliferation via p53-dependent and -independent pathways

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Mizuno, Shiro ^a   Bogaard, Herman J ^b   Voelkel, Norbert F ^b   Umeda, Yukihiro ^a   Kadowaki, Maiko ^a   Ameshima, Shingo ^a   Miyamori, Isamu ^a   Ishizaki, Takeshi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; DEFEROXAMINE; OXYGEN; PROTEIN P21; PROTEIN P27; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CDKN1B PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; IRON CHELATING AGENT; SIGNAL PEPTIDE; SMALL INTERFERING RNA; TP53 PROTEIN, HUMAN;

ARTICLE; CELL PROLIFERATION; DNA SYNTHESIS; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA; LUNG FIBROBLAST; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; CELL CULTURE; CELL CYCLE; CELL HYPOXIA; DNA REPLICATION; DRUG EFFECT; FIBROBLAST; GENETIC TRANSFECTION; GENETICS; LUNG; METABOLISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

CELL CYCLE; CELL HYPOXIA; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DEFEROXAMINE; DNA REPLICATION; FIBROBLASTS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; IRON CHELATING AGENTS; LUNG; OXYGEN; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 65649117863     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-17     Document Type: Article

References (54)

1. Olman MA, White KE, Ware LB, Simmons WL, Benveniste EN, Zhu S, Pugin J, Matthay MA. Pulmonary edema fluid from patients with early lung injury stimulates fibroblast proliferation through IL-1 beta-induced IL-6 expression. J Immunol 2004, 172(4):2668-2677.
2. Shahar I, Fireman E, Topilsky M, Grief J, Schwarz Y, Kivity S, Ben-Efraim S, Spirer Z. Effect of endothelin-1 on alpha-smooth muscle actin expression and on alveolar fibroblasts proliferation in interstitial lung diseases. Int J Immunopharmacol 1999, 21(11):759-775. 10.1016/S0192-0561(99)00056-9, 10576621.
3. Cogo A, Napolitano G, Michoud MC, Barbon DR, Ward M, Martin JG. Effects of hypoxia on rat airway smooth muscle cell proliferation. J Appl Physiol 2003, 94(4):1403-1409.
4. Helfman T, Falanga V. Gene expression in low oxygen tension. Am J Med Sci 1993, 306(1):37-41. 10.1097/00000441-199307000-00010, 8328508.
5. Björnheden T, Levin M, Evaldsson M, Wiklund O. Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler Thromb Vasc Biol 1999, 19(4):870-876.
6. Papakonstantinou E, Karakiulakis G, Tamm M, Perruchoud AP, Roth M. Hypoxia modifies the effect of PDGF on glycosaminoglycan synthesis by primary human lung cells. Am J Physiol Lung Cell Mol Physiol 2000, 279(5):L825-834.
7. Horino Y, Takahashi S, Miura T, Takahashi Y. Prolonged hypoxia accelerates the posttranscriptional process of collagen synthesis in cultured fibroblasts. Life Sci 2002, 71(26):3031-3045. 10.1016/S0024-3205(02)02142-2, 12408871.
8. Leufgen H, Bihl MP, Rüdiger JJ, Gambazzi J, Perruchoud AP, Tamm M, Roth M. Collagenase expression and activity is modulated by the interaction of collagen types, hypoxia, and nutrition in human lung cells. J Cell Physiol 2005, 204(1):146-154. 10.1002/jcp.20289, 15672417.
9. Karakiulakis G, Papakonstantinou E, Aletras AJ, Tamm M, Roth M. Cell type-specific effect of hypoxia and platelet-derived growth factor-BB on extracellular matrix turnover and its consequences for lung remodeling. J Biol Chem 2007, 282(2):908-915. 10.1074/jbc.M602178200, 17099219.
10. Groves BM, Reeves JT, Sutton JR, Wagner PD, Cymerman A, Malconian MK, Rock PB, Young PM, Houston CS. Operation Everest II: elevated high-altitude pulmonary resistance unresponsive to oxygen. J Appl Physiol 1987, 63(2):521-530.
11. Hainsworth R, Drinkhill MJ. Cardiovascular adjustments for life at high altitude. Respir Physiol Neurobiol 2007, 158(2-3):204-211. 10.1016/j.resp.2007.05.006, 17597013.
12. Biernacki W, Flenley DC, Muir AL, MacNee W. Pulmonary hypertension and right ventricular function in patients with COPD. Chest 1988, 94(6):1169-75. 10.1378/chest.94.6.1169, 3191757.
13. MacNee W. Part One Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994, 150(3):833-852. Part One.
14. Semmens M, Reid L. Pulmonary arterial muscularity and right ventricular hypertrophy in chronic bronchitis and emphysema. Br J Dis Chest 1974, 68:253-263.
15. Hatakeyama M, Weinberg RA. The role of RB in cell cycle control. Prog Cell Cycle Res 1995, 1:9-19.
16. Fukuchi K, Tomoyasu S, Watanabe H, Tsuruoka N, Gomi K. G1 accumulation caused by iron deprivation with deferoxamine does not accompany change of pRB status in ML-1 cells. Biochim Biophys Acta 1997, 1357(3):297-305. 10.1016/S0167-4889(97)00040-2, 9268054.
17. Gardner LB, Li Q, Park MS, Flanagan WM, Semenza GL, Dang CV. Hypoxia inhibits G1/S transition through regulation of p27 expression. J Biol Chem 2001, 276(11):7919-7926. 10.1074/jbc.M010189200, 11112789.
18. Norman JT, Clark IM, Garcia PL. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 2000, 58(6):2351-2366. 10.1046/j.1523-1755.2000.00419.x, 11115069.
19. Sahai A, Mei C, Pattison TA, Tannen RL. Chronic hypoxia induces proliferation of cultured mesangial cells: role of calcium and protein kinase C. Am J Physiol 1997, 273(6 Pt 2):F954-960.
20. Adachi S, Ito H, Tamamori-Adachi M, Ono Y, Nozato T, Abe S, Ikeda M, Marumo F, Hiroe M. Cyclin A/cdk2 activation is involved in hypoxia-induced apoptosis in cardiomyocytes. Circ Res 2001, 88(4):408-414.
21. Roy S, Khanna S, Bickerstaff AA, Subramanian SV, Atalay M, Bierl M, Pendyala S, Levy D, Sharma N, Venojarvi M, Strauch A, Orosz CG, Sen CK. Oxygen sensing by primary cardiac fibroblasts: a key role of p21Waf1/Cip1/Sdi1. Circ Res 2003, 92(3):264-271. 10.1161/01.RES.0000056770.30922.E6, 12595337.
22. Graff P, Amellem O, Seim J, Stokke T, Pettersen EO. The role of p27 in controlling the oxygen-dependent checkpoint of mammalian cells in late G1. Anticancer Res 2005, 25(3B):2259-2267.
23. Wang G, Reisdorph R, Clark RE, Miskimins R, Lindahl R, Miskimins WK. Cyclin dependent kinase inhibitor p27Kip1 is upregulated by hypoxia via an ARNT dependent pathway. J Cell Biochem 2003, 90(3):548-560. 10.1002/jcb.10621, 14523989.
24. Yu L, Quinn DA, Garg HG, Hales CA. Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice. Cir Res 2005, 97(9):937-945.
25. Yu L, Quinn DA, Garg HG, Hales CA. Gene expression of cyclin-dependent kinase inhibitors and effect of heparin on their expression in mice with hypoxia-induced pulmonary hypertension. Biochem Biophys Res Commun 2006, 345(4):1565-1572. 10.1016/j.bbrc.2006.05.060, 16729969.
26. Mizuno S, Kadowaki M, Demura Y, Ameshima S, Miyamori I, Ishizaki T. p42/44 Mitogen-activated protein kinase regulated by p53 and nitric oxide in human pulmonary arterial smooth muscle cells. Am J Respir Cell Mol Biol 2004, 31(2):184-192. 10.1165/rcmb.2003-0397OC, 15016620.
27. O'Reilly MA, Staversky RJ, Watkins RH, Reed CK, de Mesy Jensen KL, Finkelstein JN, Keng PC. The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress. Am J Respir Cell Mol Biol 2001, 24(6):703-710.
28. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996, 379(6560):88-91. 10.1038/379088a0, 8538748.
29. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci USA 2003, 100(4):1931-1936. 149936, 12574499, 10.1073/pnas.2627984100.
30. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 1998, 392(6674):405-408. 10.1038/32925, 9537326.
31. Blagosklonny MV, An WG, Romanova LY, Trepel J, Fojo T, Neckers L. p53 inhibits hypoxia-inducible factor-stimulated transcription. J Biol Chem 1998, 273(20):11995-11998. 10.1074/jbc.273.20.11995, 9575138.
32. Ashcroft M, Taya Y, Vousden KH. Stress signals utilize multiple pathways to stabilize p53. Mol Cell Biol 2000, 20(9):3224-3233. 85616, 10757806, 10.1128/MCB.20.9.3224-3233.2000.
33. Koumenis C, Alarcon R, Hammond E, Sutphin P, Hoffman W, Murphy M, Derr J, Taya Y, Lowe SW, Kastan M, Giaccia A. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol 2001, 21(4):1297-1310. 99582, 11158315, 10.1128/MCB.21.4.1297-1310.2001.
34. Le NT, Richardson DR. Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation. Carcinogenesis 2003, 24(6):1045-1058. 10.1093/carcin/bgg042, 12807743.
35. Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ, Giaccia AJ. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 1994, 14(9):6264-6277. 359153, 8065358.
36. López-Barneo J, del Toro R, Levitsky KL, Chiara MD, Ortega-Sáenz P. Regulation of oxygen sensing by ion channels. J Appl Physiol 2004, 96(3):1187-1195. 10.1152/japplphysiol.00929.2003, 14766769.
37. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R, Beaty T, Sham JS, Wiener CM, Sylvester JT, Semenza GL. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1a. J Clin Invest 1999, 103(5):691-696. 408131, 10074486, 10.1172/JCI5912.
38. Krick S, Hanze J, Eul B, Savai R, Seay U, Grimminger F, Lohmeyer J, Klepetko W, Seeger W, Rose F. Hypoxia-driven proliferation of human pulmonary artery fibroblasts: cross-talk between HIF-1alpha and an autocrine angiotensin system. FASEB J 2005, 19(7):857-859.
39. Rose F, Grimminger F, Appel J, Heller M, Pies V, Weissmann N, Fink L, Schmidt S, Krick S, Camenisch G, Gassmann M, Seeger W, Hänze J. Hypoxic pulmonary artery fibroblasts trigger proliferation of vascular smooth muscle cells: role of hypoxia-inducible transcription factors. FASEB J 2002, 16(12):1660-1661.
40. Eul B, Rose F, Krick S, Savai R, Goyal P, Klepetko W, Grimminger F, Weissmann N, Seeger W, Hänze J. Impact of HIF-1alpha and HIF-2alpha on proliferation and migration of human pulmonary artery fibroblasts in hypoxia. FASEB J 2006, 20(1):163-165.
41. Welsh DJ, Scott P, Plevin R, Wadsworth R, Peacock AJ. Hypoxia enhances cellular proliferation and inositol 1,4, 5-triphosphate generation in fibroblasts from bovine pulmonary artery but not from mesenteric artery. Am J Respir Crit Care Med 1998, 158(6):1757-1762.
42. Falanga V, Kirsner RS. Low oxygen stimulates proliferation of fibroblasts seeded as single cells. J Cell Physiol 1993, 154(3):506-510. 10.1002/jcp.1041540308, 8436599.
43. Munro J, Steeghs K, Morrison V, Ireland H, Parkinson EK. Human fibroblast replicative senescence can occur in the absence of extensive cell division and short telomeres. Oncogene 2001, 20(27):3541-3552. 10.1038/sj.onc.1204460, 11429701.
44. Collado M, Medema RH, Garcia-Cao I, Dubuisson ML, Barradas M, Glassford J, Rivas C, Burgering BM, Serrano M, Lam EW. Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1. J Biol Chem 2000, 275(29):21960-21968. 10.1074/jbc.M000759200, 10791951.
45. Kadowaki M, Mizuno S, Demura Y, Ameshima S, Miyamori I, Ishizaki T. Effect of hypoxia and Beraprost sodium on human pulmonary arterial smooth muscle cell proliferation: the role of p27kip1. Respir Res 2007, 8(77). 2164950, 17974037.
46. Brown JP, Wei W, Sedivy JM. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997, 277(5327):831-834. 10.1126/science.277.5327.831, 9242615.
47. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 1995, 92(12):5545-5549. 41732, 7777546, 10.1073/pnas.92.12.5545.
48. Esposito F, Cuccovillo F, Russo L, Casella F, Russo T, Cimino F. A new p21waf1/cip1 isoform is an early event of cell response to oxidative stress. Cell Death Differ 1998, 5(11):940-945. 10.1038/sj.cdd.4400427, 9846180.
49. Esposito F, Cuccovillo F, Vanoni M, Cimino F, Anderson CW, Appella E, Russo T. Redox-mediated regulation of p21waf1/cip1 expression involves a post-transcriptional mechanism and activation of the mitogen-activated protein kinase pathway. Eur J Biochem 1997, 245(3):730-737. 10.1111/j.1432-1033.1997.00730.x, 9183012.
50. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387(6630):296-299. 10.1038/387296a0, 9153395.
51. Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 1998, 396(6707):177-180. 10.1038/24179, 9823898.
52. Philipp-Staheli J, Kim KH, Liggitt D, Gurley KE, Longton G, Kemp CJ. Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development. Oncogene 2004, 23(4):905-913. 10.1038/sj.onc.1207220, 14647411.
53. Philipp-Staheli J, Kim KH, Payne SR, Gurley KE, Liggitt D, Longton G, Kemp CJ. Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice. Cancer Cell 2002, 1(4):355-368. 10.1016/S1535-6108(02)00054-5, 12086850.
54. Wu RC, Schönthal AH. Activation of p53-p21waf1 pathway in response to disruption of cell-matrix interactions. J Biol Chem 1997, 272(46):29091-29098. 10.1074/jbc.272.46.29091, 9360984.